Baxter Heparin Lawsuit Origin
All Baxter Heparin lawsuits originate from a spike of reports detailing the adverse effects of Heparin injections used in dialysis centers. In January 2008, 350 reports describing the harmful effects of Baxter Heparin were collected by Baxter Healthcare and the US Food and Drug Administration.
Baxter Heparin Lawsuit Investigation
Due to the quantity of Baxter Heparin products in the market – over half a million sold per month and nearly ubiquitous use in many medical facilities – Baxter Healthcare, the Centers for Disease Control, and the FDA all launched their respective investigations.
In February 2008, the investigations discovered that the prime ingredient for the Baxter Heparin lots was manufactured by suppliers in China.
A Baxter Heparin lawsuit will implicate Baxter Healthcare and those companies involved with the production and marketing of the components used for the contaminated Heparin.
Baxter Heparin Lawsuit Details
On March 2008, a contaminant was traced to a Chinese factory owned and operated by Scientific Protein Laboratories LLC, a company based in Wisconsin.
The US FDA identified the contaminant as an abundant and inexpensive compound. The compound is similar to the Heparin molecule, and as such, routine preliminary tests were unable to detect it.
Any Baxter Heparin lawsuits will pursue an investigation regarding the similarity between the Heparin and the contaminant molecules, and if the similarity was intentionally exploited to manufacture a cheaper Heparin product to the detriment of its end users.
Baxter Heparin Lawsuit Accountability
In the definite event of a Baxter Heparin lawsuit, Baxter Healthcare will be held accountable for its negligence and its inability to monitor its international operations to ensure the safety of its products. Considering that Heparin is used extensively in medical centers, the pharmaceutical giant and its ability to monitor such an essential and common drug will be put into question.
The Baxter Heparin lawsuit will also implicate Scientific Protein Laboratories as the producer of the contaminant found in the Heparin vials. Upon a thorough and grossly overdue inspection, the FDA found the SPL Chinese factory to have alarming deficiencies and violations.
The Baxter Heparin lawsuit will undoubtedly cite the violations of the SPL factory – incomplete manufacturing instructions for Heparin, lack of impurity profile for Heparin, deficient products approved for sale.
Baxter Heparin Lawsuit Lawyers
The attorneys at Babbitt-Johnson are currently investigating Baxter Healthcare and Scientific Protein Laboratories for their involvement in mass producing the poisonous and the potentially lethal vials of Heparin. If you know someone who has undergone dialysis, major surgery, or suspect the use of Baxter Heparin, consult a physician immediately. Babbitt-Johnson offers free legal consultations for victims of Baxter Heparin and its adverse effects.
It is imperative to consult a physician as soon as possible. Babbitt-Johnson attorneys, specializing in aprotinin and Trasylol cases, offer free legal consultations and advice on the best legal recourses.
|
